Medicare Enrolled
Dr. Augusto Villegas, MD
Medical Oncology · Fleming Island, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Villegas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Villegas? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Villegas
Dr. Augusto Villegas is a medical oncology in Fleming Island, FL, with 20 years in practice. Based on federal Medicare data, Dr. Villegas performed 36,186 Medicare services across 1,548 unique beneficiaries.
Between the years covered by Open Payments, Dr. Villegas received a total of $135,436 from 98 pharmaceutical and/or device companies across 931 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Villegas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 38% volume in FL$ $135,436 industry payments
Medicare Practice Summary
Medicare Utilization ↗36,186
Medicare services
Top 38% in FL for medical oncology
1,548
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,809 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 10,200 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 6,060 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 5,520 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 5,070 | $1 | $5 |
| Iron infusion (Monoferric) | 2,700 | $17 | $57 |
| Dexamethasone injection (steroid) | 1,700 | $0 | $3 |
| Blood draw (venipuncture) | 884 | $8 | $9 |
| Complete blood count (CBC) with differential | 846 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 610 | $1 | $28 |
| Office visit, established patient (20-29 min) | 536 | $63 | $239 |
| Drug injection, under skin or into muscle | 436 | $10 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 288 | $22 | $84 |
| Office visit, established patient (30-39 min) | 288 | $92 | $339 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 186 | $46 | $189 |
| Administration of chemotherapy into vein, 1 hour or less | 177 | $99 | $378 |
| Injection, zoledronic acid, 1 mg | 115 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 75 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 72 | $21 | $79 |
| Hospital follow-up visit, moderate complexity | 69 | $63 | $197 |
| Injection of drug or substance into vein | 66 | $28 | $156 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 63 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 45 | $49 | $178 |
| Injection of additional new drug or substance into vein | 40 | $11 | $61 |
| Initial hospital admission, high complexity | 37 | $137 | $556 |
| Office visit, established patient, complex (40-54 min) | 30 | $135 | $474 |
| New patient office visit (45-59 min) | 26 | $115 | $453 |
| Initial hospital admission, moderate complexity | 18 | $103 | $377 |
| Infusion, normal saline solution , 1000 cc | 16 | $2 | $7 |
| New patient office visit, complex (60-74 min) | 13 | $173 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.0% high complexity
55.3% medium
7.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$135,436
Total received (2018-2024)
Avg $19,348/year across 7 years
Top 7% in FL for medical oncology
98
Companies
931
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$74,395 (54.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$48,735 (36.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,306 (9.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,300
2023$3,961
2022$8,067
2021$12,401
2020$26,540
2019$36,830
2018$45,337
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$81,302
Gilead Sciences, Inc.
$12,414
Seattle Genetics, Inc.
$8,953
Bayer HealthCare Pharmaceuticals Inc.
$4,585
E.R. Squibb & Sons, L.L.C.
$3,675
Seagen Inc.
$2,801
AstraZeneca UK Limited
$2,775
Karyopharm Therapeutics Inc.
$2,263
GENZYME CORPORATION
$2,257
NOVARTIS PHARMACEUTICALS CORPORATION
$1,818
Amgen Inc.
$1,255
Novartis Pharmaceuticals Corporation
$1,104
PFIZER INC.
$789
F. Hoffmann-La Roche AG
$776
Merck Sharp & Dohme Corporation
$613
Genentech USA, Inc.
$535
Merck Sharp & Dohme LLC
$525
Janssen Biotech, Inc.
$488
Takeda Pharmaceuticals U.S.A., Inc.
$476
Celgene Corporation
$414
Alexion Pharmaceuticals, Inc.
$337
Astellas Pharma US Inc
$322
GlaxoSmithKline, LLC.
$284
Exelixis Inc.
$278
Eisai Inc.
$257
Incyte Corporation
$234
Lilly USA, LLC
$221
Kite Pharma, Inc.
$200
Daiichi Sankyo Inc.
$190
Regeneron Healthcare Solutions, Inc.
$174
EMD Serono, Inc.
$168
Ipsen Biopharmaceuticals, Inc
$151
ARRAY BIOPHARMA INC
$120
JAZZ PHARMACEUTICALS INC.
$115
Novocure Inc.
$114
Mirati Therapeutics, Inc.
$104
Taiho Oncology, Inc.
$98
AbbVie Inc.
$94
Rigel Pharmaceuticals, Inc.
$91
BeiGene USA, Inc.
$87
EISAI INC.
$84
MorphoSys, US Inc.
$81
G1 Therapeutics, Inc.
$81
Global Blood Therapeutics, Inc.
$79
SERVIER PHARMACEUTICALS LLC
$72
TESARO, Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Epizyme, Inc.,
$65
Dendreon Pharmaceuticals LLC
$62
ABBVIE INC.
$61
Lexicon Pharmaceuticals, Inc.
$52
AVEO Pharmaceuticals, Inc.
$51
Foundation Medicine, Inc.
$48
Myriad Genetic Laboratories, Inc.
$48
ADC Therapeutics America, Inc.
$46
Progenics Pharmaceuticals, Inc.
$45
Dova Pharmaceuticals
$44
TerSera Therapeutics LLC
$41
Emmaus Medical, Inc.
$40
INSYS Therapeutics Inc
$40
Pharmacosmos Therapeutics Inc.
$38
Deciphera Pharmaceuticals Inc.
$38
Pharmacyclics LLC, An AbbVie Company
$36
TAIHO ONCOLOGY, INC.
$34
Sirtex Medical Inc
$33
Napo Pharmaceuticals Inc
$32
Adaptive Biotechnologies Corporation
$32
Bayer Healthcare Pharmaceuticals Inc.
$30
CSL Behring
$29
Sun Pharmaceutical Industries Inc.
$26
PharmaEssentia USA Corporation
$26
Aurobindo Pharma USA, Inc.
$26
Stemline Therapeutics Inc.
$25
Octapharma USA, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$24
Fennec Pharmaceuticals, Inc.
$24
Lundbeck LLC
$23
Blue Earth Diagnostics Limited
$21
CTI BioPharma Corp.
$21
Aveo Pharmaceuticals, Inc.
$19
Array BioPharma Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$17
TG Therapeutics, Inc.
$17
TG THERAPEUTICS, INC.
$17
Clovis Oncology, Inc.
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
AMAG Pharmaceuticals, Inc.
$15
Blueprint Medicines Corporation
$14
Teva Pharmaceuticals USA, Inc.
$14
Agios Pharmaceuticals, Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Secura Bio, Inc.
$13
Puma Biotechnology, Inc.
$13
SECURA BIO, INC.
$13
Pharmacyclics LLC, an AbbVie Company
$12
Myovant Sciences Inc.
$12
Janssen Pharmaceuticals, Inc
$10
Veracyte, Inc.
$1
Top 3 companies account for 75.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Afstyla · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · Endari · Enhertu · Erivedge · Erleada · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAVRETO · GAZYVA · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Marqibo · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · ODOMZO (sonidegib) capsules · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYLARIFY · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VIJOICE · VOTRIENT · VYEPTI · Vectibix · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · Zydelig · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for medical oncology in FL.
Equivalent to $374 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
13
Per 100K population
5.8
County median income
$86,094
Nearest hospital
HCA FLORIDA ORANGE PARK HOSPITAL
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Villegas is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 7%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Villegas experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Villegas performed 10,200 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Villegas receive payments from pharmaceutical companies?
Yes. Dr. Villegas received a total of $135,436 from 98 companies across 931 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Villegas's costs compare to other medical oncologys in Fleming Island?
Dr. Villegas's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Villegas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Fleming Island
Browse medical oncologys in Fleming Island ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc..
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology